- 产品描述
- 产品组分
- 文件资源
- 营销中心
- 注意事项
- FAQ
- 文献追踪
-
通用DNA-蛋白质结合检测试剂盒(比色法)设计用于测量核提取物中DNA结合活性的转录因子。在使用该试剂盒的检测中,将含有目标转录因子的DNA结合共识序列的生物素标记的双链寡核苷酸(oligo)与核提取物在结合检测缓冲液中进行孵化。核提取物中的转录因子的活性形式与它的共识序列结合。然后寡聚物-蛋白质复合物被捕获到检测微孔上。目标蛋白可以被一个高亲和力的抗体识别,并通过检测抗体-显色试剂反应系统进行比色测量。
通用DNA-蛋白质结合检测试剂盒(比色法)是一个方便的工具包,使实验者能够有效地在体外研究蛋白质-DNA相互作用。整个过程可在3小时内完成,并产生比任何竞争者的试剂盒更优越的结果。通用DNA-蛋白质结合检测试剂盒(比色法)适用于分析体外的蛋白质-DNA相互作用,特别是利用哺乳动物组织和细胞提取物检测转录因子的激活。
合作开发的通用DNA-蛋白质结合检测试剂盒(比色法),具有如下的优势和特性:
- 最快的程序:一个完整的检测可以在3小时内完成。
- 条形微孔板格式使检测灵活:手动或高通量分析。
- 比色法量化蛋白质的活化,使用无放射性的材料:处理起来更安全。
- 简单、可靠、一致的检测条件。
关键词:- 通用DNA-蛋白质结合检测试剂盒(比色法)
-
产品组分
*注意:在使用之前,为了最大限度的利用产品,请在开盖之前离心溶液至管底。在使用之前,将冷冻的试剂瓶约5~10分钟恢复到室温。组分内容
型号:A-P-2004-96(96次)
型号:A-P-2004-192(192次) 储存温度
PD1
10X Wash Buffer
20 ml 40ml 4°C PD2 Assay Binding Buffer 4 ml 8 ml 4°C PD3 Antibody Dilution Buffer 20 ml 40 ml 4°C PD4 Developing Solution
10 ml 20 ml 4°C PD5 Stop Solution
6 ml 12 ml 室温 8-Well Assay Strips(With Frame) 12 24 4°C 操作手册
1
1
室温
-
文件资源
文件下载 文件内容 资源说明 
A-P-2004-通用DNA-蛋白质结合检测试剂盒(比色法) 操作手册 
A-P-2004-通用DNA-蛋白质结合检测试剂盒(比色法)相关产品 宣传单页 -
注意事项
保存建议 推荐蓝冰或冰袋运输。当您收到产品后,按照说明书建议保存各组分。 警告 本品仅供科研使用,请勿用于临床与诊断。 -
FAQ

-
Yazar V et. al. (November 2021). Integrative genome-wide analysis of dopaminergic neuron-specific PARIS expression in Drosophila dissects recognition of multiple PPAR-γ associated gene regulation. Sci Rep. 11(1):21500.
Huang R. et. al. (August 2021). KLF4 transactivates TRIM29 expression and modulates keratin network Biochemistry and Biophysics Reports. 28
Cruz RGB et. al. (February 2021). Human Epidermal Growth Factor Receptor-3 Expression Is Regulated at Transcriptional Level in Breast Cancer Settings by Junctional Adhesion Molecule-A via a Pathway Involving Beta-Catenin and FOXA1. Cancers (Basel). 13(4)
Huang Y et. al. (February 2021). Endogenous SO<sub>2</sub>-dependent Smad3 redox modification controls vascular remodeling. Redox Biol. 41:101898.
Zhou X et. al. (January 2021). Uranium directly interacts with the DNA repair protein poly (ADP-ribose) polymerase 1. Toxicol Appl Pharmacol. 410:115360.
Zhou X et. al. (November 2020). Inhibition of red blood cell development by arsenic-induced disruption of GATA-1. Sci Rep. 10(1):19055.
Liu X et. al. (January 2020). Expression of the prosurvival kinase HCK requires PAX5 and mutated MYD88 signaling in MYD88-driven B-cell lymphomas. Blood Adv. 4(1):141-153.
Belli M et. al. (August 2019). FOXO1 negates the cooperative action of FOXL2C134W and SMAD3 in CYP19 expression in HGrC1 cells by sequestering SMAD3 Journal of the Endocrine Society.
Hekmat-Scafe DS et. al. (November 2016). Using yeast to determine the functional consequences of mutations in the human p53 tumor suppressor gene: An introductory course-based undergraduate research experience in molecular and cell biology. Biochem Mol Biol Educ.
Jang JY et. al. (February 2016). Targeting adenine nucleotide translocase-2 (ANT2) to overcome resistance to epidermal growth factor receptor tyrosine kinase inhibitor in non-small cell lung cancer. Mol Cancer Ther.
Koh J et. al. (October 2015). EML4-ALK enhances programmed cell death-ligand 1 expression in pulmonary adenocarcinoma via hypoxia-inducible factor (HIF)-1α and STAT3 OncoImmunology.
Gao Y The Univer et. al. (June 2014). Up-regulation of Hepatic VLDLR via PPARα Is Required for the Triglyceride-Lowering Effect of Fenofibrate. J Lipid Res.
Klengel T et. al. (January 2013). Allele-specific FKBP5 DNA demethylation mediates gene-childhood trauma interactions. Nat Neurosci. 16(1):33-41.
猜你喜欢
在线留言
如果您对我们的产品感兴趣,请留下您的信息,我们将尽快与您联系,谢谢!
艾维缔官网
艾德官网
B站IVDSHOW
抖音军哥聊表观
视频号艾维缔
小红书艾维缔
快手表观盒子
表观遗传学
联系我们
